0001752724-23-218478.txt : 20230927 0001752724-23-218478.hdr.sgml : 20230927 20230927091410 ACCESSION NUMBER: 0001752724-23-218478 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230731 FILED AS OF DATE: 20230927 DATE AS OF CHANGE: 20230927 PERIOD START: 20231031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSAMERICA FUNDS CENTRAL INDEX KEY: 0000787623 IRS NUMBER: 000000000 FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-04556 FILM NUMBER: 231282112 BUSINESS ADDRESS: STREET 1: 1801 CALIFORNIA STREET STREET 2: SUITE 5200 CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 720-482-8836 MAIL ADDRESS: STREET 1: 1801 CALIFORNIA STREET STREET 2: SUITE 5200 CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: TRANSAMERICA IDEX MUTUAL FUNDS DATE OF NAME CHANGE: 20040301 FORMER COMPANY: FORMER CONFORMED NAME: IDEX MUTUAL FDS DATE OF NAME CHANGE: 20010504 FORMER COMPANY: FORMER CONFORMED NAME: IDEX MUTUAL FUNDS / DATE OF NAME CHANGE: 20010423 0000787623 S000080098 Transamerica Sustainable Growth Equity C000241765 R6 C000241767 A NPORT-P 1 primary_doc.xml NPORT-P false 0000787623 XXXXXXXX S000080098 C000241765 C000241767 TRANSAMERICA FUNDS 811-04556 0000787623 54930088ZHZE1VMYEY52 1801 CALIFORNIA STREET SUITE 5200 DENVER 80202 720-493-4256 Transamerica Sustainable Growth Equity S000080098 54930002XICYHY14QD76 2023-10-31 2023-07-31 N 5712843.35 19578.85 5693264.50 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 35413.81000000 N Salesforce Inc RCGZFPDMRW58VJ54VR07 Salesforce, Inc. 79466L302 795.00000000 NS USD 178882.95000000 3.142010177113 Long EC CORP US N 1 N N N AMETEK Inc 549300WZDEF9KKE40E98 AMETEK, Inc. 031100100 565.00000000 NS USD 89609.00000000 1.573947600713 Long EC CORP US N 1 N N N UnitedHealth Group Inc 549300GHBMY8T5GXDE41 UnitedHealth Group, Inc. 91324P102 305.00000000 NS USD 154442.85000000 2.712729225912 Long EC CORP US N 1 N N N Costco Wholesale Corp 29DX7H14B9S6O3FD6V18 Costco Wholesale Corp. 22160K105 305.00000000 NS USD 171004.35000000 3.003625600040 Long EC CORP US N 1 N N N Teradyne Inc C3X4YJ278QNZHRJULN75 Teradyne, Inc. 880770102 810.00000000 NS USD 91481.40000000 1.606835586156 Long EC CORP US N 1 N N N Splunk Inc 549300XGDSGBP6UEI867 Splunk, Inc. 848637104 860.00000000 NS USD 93163.80000000 1.636386294717 Long EC CORP US N 1 N N N WillScot Mobile Mini Holdings Corp 549300HJ4VIXF476Q166 WillScot Mobile Mini Holdings Corp. 971378104 2210.00000000 NS USD 105969.50000000 1.861313487191 Long EC CORP US N 1 N N N Alphabet Inc 5493006MHB84DD0ZWV18 Alphabet, Inc. 02079K305 1625.00000000 NS USD 215670.00000000 3.788160553580 Long EC CORP US N 1 N N N Visa Inc 549300JZ4OKEHW3DPJ59 Visa, Inc. 92826C839 885.00000000 NS USD 210391.05000000 3.695437828332 Long EC CORP US N 1 N N N Ascendis Pharma A/S 549300B66JN3W3J8GH73 Ascendis Pharma AS 04351P101 1535.00000000 NS USD 138380.25000000 2.430595838292 Long EC CORP DK N 1 N N N Inspire Medical Systems Inc 549300XQQCQ7HCJKTW25 Inspire Medical Systems, Inc. 457730109 350.00000000 NS USD 100733.50000000 1.769345162164 Long EC CORP US N 1 N N N ChampionX Corp 549300EP2909K6DYYP38 ChampionX Corp. 15872M104 1220.00000000 NS USD 43432.00000000 0.762866366036 Long EC CORP US N 1 N N N Workday Inc 549300J0DYC0N31V7G13 Workday, Inc. 98138H101 425.00000000 NS USD 100780.25000000 1.770166307924 Long EC CORP US N 1 N N N CDW Corp/DE 9845001B052ABF0B6755 CDW Corp. 12514G108 555.00000000 NS USD 103823.85000000 1.823625970653 Long EC CORP US N 1 N N N Microsoft Corp INR2EJN1ERAN0W5ZP974 Microsoft Corp. 594918104 2085.00000000 NS USD 700393.20000000 12.30213702525 Long EC CORP US N 1 N N N Applied Materials Inc 41BNNE1AFPNAZELZ6K07 Applied Materials, Inc. 038222105 690.00000000 NS USD 104597.10000000 1.837207809333 Long EC CORP US N 1 N N N NVIDIA Corp 549300S4KLFTLO7GSQ80 NVIDIA Corp. 67066G104 635.00000000 NS USD 296729.15000000 5.211933329287 Long EC CORP US N 1 N N N Hubbell Inc 54930088VDQ6840Y6597 Hubbell, Inc. 443510607 355.00000000 NS USD 110760.00000000 1.945456776160 Long EC CORP US N 1 N N N Alphabet Inc 5493006MHB84DD0ZWV18 Alphabet, Inc. 02079K107 1640.00000000 NS USD 218300.40000000 3.834362517322 Long EC CORP US N 1 N N N Fortinet Inc 549300O0QJWDBAS0QX03 Fortinet, Inc. 34959E109 1230.00000000 NS USD 95595.60000000 1.679099925886 Long EC CORP US N 1 N N N Cadence Design Systems Inc GCT7RXJOGLXPV0NXZY22 Cadence Design Systems, Inc. 127387108 325.00000000 NS USD 76053.25000000 1.335846068630 Long EC CORP US N 1 N N N ICON PLC 6354008SRQGEMC4XFI67 ICON PLC 000000000 425.00000000 NS USD 106849.25000000 1.876765957387 Long EC CORP IE N 1 N N N Bright Horizons Family Solutions Inc N/A Bright Horizons Family Solutions, Inc. 109194100 570.00000000 NS USD 55307.10000000 0.971447927634 Long EC CORP US N 1 N N N ServiceNow Inc 549300HJTQM36M0E1G39 ServiceNow, Inc. 81762P102 190.00000000 NS USD 110770.00000000 1.945632422312 Long EC CORP US N 1 N N N Bio-Techne Corp 54930073RLKQ51TILZ35 Bio-Techne Corp. 09073M104 940.00000000 NS USD 78396.00000000 1.376995570818 Long EC CORP US N 1 N N N Lululemon Athletica Inc 549300D9GZ4BMLDW5T40 Lululemon Athletica, Inc. 550021109 190.00000000 NS USD 71920.70000000 1.263259418212 Long EC CORP US N 1 N N N Avery Dennison Corp 549300PW7VPFCYKLIV37 Avery Dennison Corp. 053611109 495.00000000 NS USD 91084.95000000 1.599872094472 Long EC CORP US N 1 N N N Bio-Rad Laboratories Inc 549300ZC1GPV35XYDK53 Bio-Rad Laboratories, Inc. 090572207 220.00000000 NS USD 89179.20000000 1.566398329113 Long EC CORP US N 1 N N N Apple Inc HWUPKR0MPOU8FGXBT394 Apple, Inc. 037833100 3210.00000000 NS USD 630604.50000000 11.07632536658 Long EC CORP US N 1 N N N Visteon Corp 549300MOVLYHRW4GGW78 Visteon Corp. 92839U206 540.00000000 NS USD 83208.60000000 1.461527037782 Long EC CORP US N 1 N N N Hexcel Corp S6Q7LW43WUBUHXY2QP69 Hexcel Corp. 428291108 1410.00000000 NS USD 99658.80000000 1.750468470242 Long EC CORP US N 1 N N N Aptiv PLC N/A Aptiv PLC 000000000 930.00000000 NS USD 101825.70000000 1.788529234852 Long EC CORP JE N 1 N N N S&P Global Inc Y6X4K52KMJMZE7I7MY94 S&P Global, Inc. 78409V104 280.00000000 NS USD 110462.80000000 1.940236572532 Long EC CORP US N 1 N N N Eli Lilly & Co FRDRIPF3EKNDJ2CQJL29 Eli Lilly & Co. 532457108 333.00000000 NS USD 151365.15000000 2.658670609805 Long EC CORP US N 1 N N N Amazon.com Inc ZXTILKJKG63JELOEG630 Amazon.com, Inc. 023135106 2680.00000000 NS USD 358262.40000000 6.292741185658 Long EC CORP US N 1 N N N Genpact Ltd 529900OSEC6Q0L4L5B35 Genpact Ltd. 000000000 1240.00000000 NS USD 44751.60000000 0.786044632214 Long EC CORP BM N 1 N N N 2023-08-29 TRANSAMERICA FUNDS Vincent Toner Vincent Toner Treasurer XXXX NPORT-EX 2 NPORT_I3A5_28348287_0723.htm HTML

Transamerica Sustainable Growth Equity

 

SCHEDULE OF INVESTMENTS

At July 31, 2023

(unaudited)

 

     Shares      Value  
COMMON STOCKS - 96.5%  
Aerospace & Defense - 1.8%  

Hexcel Corp.

     1,410        $  99,659  
     

 

 

 
Automobile Components - 3.2%  

Aptiv PLC (A)

     930        101,826  

Visteon Corp. (A)

     540        83,208  
     

 

 

 
        185,034  
     

 

 

 
Biotechnology - 2.4%  

Ascendis Pharma AS, ADR (A)

     1,535        138,380  
     

 

 

 
Broadline Retail - 6.3%  

Amazon.com, Inc. (A)

     2,680        358,262  
     

 

 

 
Capital Markets - 1.9%  

S&P Global, Inc.

     280        110,463  
     

 

 

 
Construction & Engineering - 1.9%  

WillScot Mobile Mini Holdings Corp. (A)

     2,210        105,970  
     

 

 

 
Consumer Staples Distribution & Retail - 3.0%  

Costco Wholesale Corp.

     305        171,004  
     

 

 

 
Containers & Packaging - 1.6%  

Avery Dennison Corp.

     495        91,085  
     

 

 

 
Diversified Consumer Services - 1.0%  

Bright Horizons Family Solutions, Inc. (A)

     570        55,307  
     

 

 

 
Electrical Equipment - 3.5%  

AMETEK, Inc.

     565        89,609  

Hubbell, Inc.

     355        110,760  
     

 

 

 
        200,369  
     

 

 

 
Electronic Equipment, Instruments & Components - 1.8%  

CDW Corp.

     555        103,824  
     

 

 

 
Energy Equipment & Services - 0.8%  

ChampionX Corp.

     1,220        43,432  
     

 

 

 
Financial Services - 3.7%  

Visa, Inc., Class A

     885        210,391  
     

 

 

 
Health Care Equipment & Supplies - 1.8%  

Inspire Medical Systems, Inc. (A)

     350        100,734  
     

 

 

 
Health Care Providers & Services - 2.7%  

UnitedHealth Group, Inc.

     305        154,443  
     

 

 

 
Interactive Media & Services - 7.6%  

Alphabet, Inc., Class A (A)

     1,625        215,670  

Alphabet, Inc., Class C (A)

     1,640        218,300  
     

 

 

 
        433,970  
     

 

 

 
Life Sciences Tools & Services - 4.8%  

Bio-Rad Laboratories, Inc., Class A (A)

     220        89,179  

Bio-Techne Corp.

     940        78,396  

ICON PLC (A)

     425        106,849  
     

 

 

 
        274,424  
     

 

 

 
Pharmaceuticals - 2.7%  

Eli Lilly & Co.

     333        151,365  
     

 

 

 
Professional Services - 0.8%  

Genpact Ltd.

     1,240        44,752  
     

 

 

 
     Shares      Value  
COMMON STOCKS (continued)  
Semiconductors & Semiconductor Equipment - 7.0%  

Applied Materials, Inc.

     690        $   104,597  

NVIDIA Corp.

     635        296,729  
     

 

 

 
        401,326  
     

 

 

 
Software - 23.8%  

Cadence Design Systems, Inc. (A)

     325        76,053  

Fortinet, Inc. (A)

     1,230        95,596  

Microsoft Corp.

     2,085        700,393  

Salesforce, Inc. (A)

     795        178,883  

ServiceNow, Inc. (A)

     190        110,770  

Splunk, Inc. (A)

     860        93,164  

Workday, Inc., Class A (A)

     425        100,780  
     

 

 

 
        1,355,639  
     

 

 

 
Technology Hardware, Storage & Peripherals - 11.1%  

Apple, Inc.

     3,210        630,605  
     

 

 

 
Textiles, Apparel & Luxury Goods - 1.3%  

Lululemon Athletica, Inc. (A)

     190        71,921  
     

 

 

 

Total Common Stocks
(Cost $4,842,832)

 

     5,492,359  
  

 

 

 

Total Investments
(Cost $4,842,832)

 

     5,492,359  

Net Other Assets (Liabilities) - 3.5%

        201,026  
     

 

 

 

Net Assets - 100.0%

        $  5,693,385  
     

 

 

 
 

 

Transamerica Funds

    Page    1         


Transamerica Sustainable Growth Equity

 

SCHEDULE OF INVESTMENTS (continued)

At July 31, 2023

(unaudited)

 

INVESTMENT VALUATION:

 

Valuation Inputs (B)

 

     Level 1 -
Unadjusted
Quoted
Prices
     Level 2 -
Other
Significant
Observable
Inputs
     Level 3 -
Significant
Unobservable
Inputs
     Value  

ASSETS

 

Investments

           

Common Stocks

   $ 5,492,359      $     —        $     —        $ 5,492,359  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Investments

   $     5,492,359      $ —        $ —        $     5,492,359  
  

 

 

    

 

 

    

 

 

    

 

 

 

FOOTNOTES TO SCHEDULE OF INVESTMENTS:

 

(A)      Non-income producing securities.
(B)      There were no transfers in or out of Level 3 during the period ended July 31, 2023. Please reference the Investment Valuation section of the Notes to Schedule of Investments for more information regarding investment valuation and pricing inputs.

PORTFOLIO ABBREVIATION:

 

ADR

   American Depositary Receipt

 

Transamerica Funds

    Page    2         


Transamerica Sustainable Growth Equity

 

NOTES TO SCHEDULE OF INVESTMENTS

At July 31, 2023

(unaudited)

 

INVESTMENT VALUATION

Transamerica Sustainable Growth Equity (the “Fund”) is a series of the Transamerica Funds.

Transamerica Asset Management, Inc. (“TAM”) has been designated as the Fund’s valuation designee pursuant to Rule 2a-5 under the Investment Company Act of 1940, as amended, with responsibility for fair valuation subject to oversight by the Fund’s Board of Trustees. The net asset value of the Fund is computed as of the official close of the New York Stock Exchange (“NYSE”) each day the NYSE is open for business.

TAM utilizes various methods to measure the fair value of its investments on a recurring basis. Generally Accepted Accounting Principles in the United States of America establishes a hierarchy that prioritizes inputs to valuation methods. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The three levels (“Levels”) of inputs of the fair value hierarchy are defined as follows:

Level 1 — Unadjusted quoted prices in active markets for identical securities.

Level 2 — Inputs, other than quoted prices included in Level 1, which are observable, either directly or indirectly. These inputs may include quoted prices for the identical instrument on an inactive market, prices for similar instruments, interest rates, prepayment speeds, credit risk, yield curves, default rates, and similar data.

Level 3 — Unobservable inputs based on the best information available in the circumstances, to the extent observable inputs are not available, which may include TAM’s own assumptions used in determining the fair value of the Fund’s investments.

The inputs used to measure fair value may fall into different Levels of the fair value hierarchy. In such cases, for disclosure purposes, the Level in the fair value hierarchy that is assigned to the fair value measurement of a security is determined based on the lowest Level input that is significant to the fair value measurement in its entirety. Certain investments that are measured at fair value using Net Asset Value per share, or its equivalent, using the “practical expedient” have not been classified in the fair value Levels. The hierarchy classification of inputs used to value the Fund’s investments at July 31, 2023, is disclosed within the Investment Valuation section of the Schedule of Investments.

The availability of observable inputs can vary from security to security and is affected by a wide variety of factors, including, but not limited to, the type of security, whether the security is new and not yet established in the marketplace, the liquidity of markets, and other characteristics particular to the security. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised in determining fair value is generally greatest for instruments categorized in Level 3. Due to the inherent uncertainty of valuation, the determination of values may differ significantly from values that would have been realized had a ready market for investments existed, and the differences could be material.

Fair value measurements: Descriptions of the valuation techniques applied to the Fund’s significant categories of assets and liabilities measured at fair value on a recurring basis are as follows:

Equity securities: Securities are stated at the last reported sales price or closing price on the day of valuation taken from the primary exchange where the security is principally traded. To the extent these securities are actively traded and valuation adjustments are not applied, they are categorized in Level 1 of the fair value hierarchy. Equities traded on inactive markets or valued by reference to similar instruments are generally categorized in Level 2 or Level 3 if inputs are unobservable.

Foreign equity securities: Securities in which the primary trading market closes at the same time or after the NYSE, are valued based on quotations from the primary market in which they are traded and are categorized in Level 1. Because many foreign securities markets and exchanges close prior to the close of the NYSE, closing prices for foreign securities in those markets or on those exchanges do not reflect the events that occur after that close. Certain foreign securities may be fair valued using a pricing service that considers the correlation of the trading patterns of the foreign security to the intraday trading in the U.S. markets for investments such as American Depositary Receipts, financial futures, or ETFs and the movement of certain indices of securities based on a statistical analysis of their historical relationship; such valuations generally are categorized in Level 2.

 

Transamerica Funds

    Page    3